Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-08-071279
Filing Date
2008-03-31
Accepted
2008-03-31 17:03:08
Documents
8
Period of Report
2007-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d10k.htm 10-K 880947
2 AMENDED AND RESTATED BYLAWS, AS AMENDED dex32.htm EX-3.2 86200
3 SUBSIDIARIES OF IVAX DIAGNOSTICS, INC. dex211.htm EX-21.1 3051
4 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM dex231.htm EX-23.1 1470
5 CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER PURSUANT TO SECTION 302 dex311.htm EX-31.1 9198
6 CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER PURSUANT TO SECTION 302 dex312.htm EX-31.2 9201
7 CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER PURSUANT TO SECTION 906 dex321.htm EX-32.1 3165
8 CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER PURSUANT TO SECTION 906 dex322.htm EX-32.2 3168
  Complete submission text file 0001193125-08-071279.txt   997875
Mailing Address 2140 NORTH MIAMI AVENUE MIAMI FL 33127
Business Address 2140 NORTH MIAMI AVENUE MIAMI FL 90802 5624917180
IVAX DIAGNOSTICS INC (Filer) CIK: 0001095858 (see all company filings)

EIN.: 113500746 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-14798 | Film No.: 08725762
SIC: 2834 Pharmaceutical Preparations